Skip to content

    Laxmi Dental

    LAXMIDENTL
    Healthcare·14 Feb 2025
    Management Summary

    Laxmi Dental reported its highest ever quarterly revenue in Q3 FY25, demonstrating strong YoY growth in revenue, EBITDA, and PAT for the nine-month period. The company is focused on strategic debt reduction, aiming for a debt-free status by FY26, and plans significant capex for digitization and capacity expansion. While Q3 PAT margins were lower than the nine-month average, management expects improvement, driven by operational efficiencies and resolution of Kids-E-Dental's regulatory delays.

    Highlights

    5
    • Revenue of ₹61.6 crores in Q3 FY25, marking the highest ever quarterly revenue.

    • EBITDA for Q3 FY25 stood at ₹9.6 crores, with an adjusted EBITDA of ₹10.8 crores.

    • For 9M FY25, revenue grew 28.8% YoY to ₹178.4 crores, and EBITDA surged 167.2% YoY to ₹32.3 crores.

    • Employee cost as a percentage of revenue reduced to 33.7% for 9M FY25 from 36.9% in the previous year.

    • The company aims to be debt-free by FY26, having already repaid ₹12.6 crores of debt in Q4 FY25.

    Concerns

    3
    • Q3 FY25 PAT margin of 7.8% was lower than the 9M FY25 PAT margin of 15% and the full-year guidance of 13-15%.

    • Delays in registration clearances for Kids-E-Dental products are impacting its near-term performance in certain countries.

    • Working capital days increased to 83 from 64, with an increase in debtors, attributed to strategic credit leeway for digital adoption.

    What Changed1

    vs Q4 FY25

    Guidance items5 → 8 (+3)
    Key financials

    Metrics

    13

    Periods

    2

    Headline

    9
    • Revenue
      ₹61.6 Cr
    • EBITDA
      ₹9.6 Cr
    • Adjusted EBITDA
      ₹10.8 Cr
    • PAT
      ₹4.8 Cr
    • Gross Margin
      73.9%

    9M

    4
    • FY25 Revenue
      ₹178.4 Cr
      YoY+28.8%
    • FY25 EBITDA
      ₹32.3 Cr
      YoY+1.7%
    • FY25 PAT
      ₹27.6 Cr
      YoY+57.3%
    • FY25 Employee Cost as % of Revenue
      33.7%

    Segment breakdown

    Share of 9M FY25 RevenueSegment Margin
    Dental Laboratory Offering62%16%
    Aligner Solutions33%24%
    Kids-E-Dental (9M FY25, not consolidated for revenue)
    Heatmap· 2 shared metrics

    Capital allocation

    2
    high confidence
    CategoryHeadline
    Capex

    ₹68.5 crores

    Debt

    Debt disclosed

    Guidance & targets

    8
    CategoryTargetPriority
    Revenue
    Top line
    ₹240 crores
    High
    Profitability
    PAT Margin
    13-15%
    High
    Profitability
    PAT Margin
    13-15%
    High
    Growth
    CAGR Growth
    20-25%
    High
    Debt
    Debt Status
    Debt-free
    High
    Finance Cost
    Finance Cost Reduction
    Considerable reduction
    High
    ESOP Expense
    ESOP Expense
    ₹2.19 crores
    High
    ESOP Expense
    ESOP Expense
    ₹6.35 crores
    High

    Kids-E-Dental Registration Clearances & Revenue Growth

    next quarter
    CurrentDelayed due to regulatory clearances
    TargetClearances received, revenue growth starts

    Why it matters

    Unlocking growth for a key pediatric dental segment and contributing to overall revenue targets.

    So the majority, the reason is we are awaiting registration clearances in countries, which we were hoping should happen in December, but due to the holiday and the extensive MDR, which is going across the world, there has been a delay on that. So the expectation is it should arrive anytime, just based on the registration authorities. So once that kicks in, we will be able to sell in those countries and then the revenue will start moving upwards.

    How to verify

    key_financials.segment_breakdown[name='Kids-E-Dental'].metrics[label='Revenue']

    Risks & concerns

    3
    RiskSeverity

    Kids-E-Dental Registration Delays

    Delays in receiving registration clearances in certain countries for Kids-E-Dental products due to holidays and MDR, impacting Q4 FY25 performance.Management acknowledged

    medium

    Increased Working Capital and Debtors

    Working capital days increased to 83 from 64, and debtors increased, which management attributes to providing credit leeway to dentists to encourage digital adoption.Analyst acknowledged

    medium

    Raw Material Price Volatility

    Minor fluctuations due to USD movement, but not seen as a major challenge due to diversified sourcing and natural hedge from exports.Management downplayed

    low

    Q&A highlights

    8

    “So one of the key drivers there was we had increase in cost. And also the plan was to repay the debt in Q3, which eventually happened. The IPO happened in Q4 and we are repaying the debt in Q4. So blended based on that the margin profile will improve in Q4 and also throughout the year as well.”

    Analyst questioned the significant gap between current quarter's PAT margin and full-year guidance, prompting management to explain cost increases and debt repayment timing.

    asked by Jatin

    3 min read8 chapters

    Detailed Narrative

    01

    Strong Q3 FY25 Performance and 9M Growth

    Laxmi Dental achieved its highest ever quarterly revenue of ₹61.6 crores in Q3 FY25, with an EBITDA of ₹9.6 crores and PAT of ₹4.8 crores. For the nine months ended December 31, 2024, the company reported a 28.8% YoY revenue growth to ₹178.4 crores. EBITDA for 9M FY25 surged 167.2% YoY to ₹32.3 crores, and PAT stood at ₹27.6 crores, marking a 57.3% YoY increase.

    02

    Margin Profile and Efficiency Focus

    The company reported a gross margin of 73.9% and an EBITDA margin of 15.6% for Q3 FY25. While the Q3 PAT margin was 7.8%, lower than the 9M average of 15%, management expects improvement, targeting 13-15% PAT margin for FY25. Employee costs as a percentage of revenue reduced to 33.7% for 9M FY25 from 36.9% last year, with further efficiencies expected from increased digitization and automation.

    03

    Strategic Debt Reduction and Capex Plans

    Utilizing IPO proceeds, Laxmi Dental has already repaid ₹12.6 crores of debt in Q4 FY25 and plans to repay a total of ₹23 crores of outstanding borrowings in Q4 FY25, aiming to be debt-free by FY26. This is expected to lead to a considerable reduction in finance costs from Q1 FY26. The company has planned a capex of ₹68.5 crores over the next two years, with ₹43.5 crores allocated for new machinery and ₹25 crores for its subsidiary Bizdent Devices Private Limited.

    04

    Product Portfolio and Segment Performance

    The dental laboratory offering, including crowns, bridges, and prostheses, constituted 62% of revenues for 9M FY25, with a segment margin of 16%. Aligner solutions contributed 33% of revenues, with a segment margin of 24%. The jointly controlled entity, Kids-E-Dental LLP, which offers preformed pediatric dental crowns, reported ₹21.5 crores in revenue and ₹10.7 crores in PAT for 9M FY25, though its revenue is not consolidated due to Ind AS norms.

    05

    Geographical Performance and Expansion

    In Q3 FY25, domestic business contributed 66% of revenues, while international business accounted for 34%. The company currently caters to customers across 95 countries and works with approximately 22,000 dentists in India. While the West region has historically been a stronghold, contributing 50% of current revenues, the company is actively expanding its reach in other regions like North, South, and East.

    06

    Digitization as a Growth Driver

    Laxmi Dental emphasizes digital dentistry, with about 60% of units produced at its domestic lab already done via digital medium. The adoption of intraoral scanners, currently at 23% globally and expected to grow to 28% by 2027, is seen as a major lever for growth. The company provides credit leeway to dentists adopting digital impressions to encourage this transition, which in turn enhances operational efficiency.

    07

    Market Opportunity and Outlook

    The Indian dental care services market is estimated at $3.4 billion in 2023, projected to grow at a CAGR of 12.6% to $7.8 billion by 2030, driven by increased awareness and demand for specialized care. The company expects to grow at a CAGR of 20-25% over the next 3-5 years, supported by increasing dental awareness, rising disposable income, and technological advancements like 3D printing and CAD-CAM.

    08

    Kids-E-Dental Regulatory Delays

    The performance of Kids-E-Dental has been impacted by delays in receiving registration clearances in certain countries. Management expects these clearances to come through, which will then allow revenue from these markets to grow. This delay is noted as a factor for the Q3 PAT margin being lower than the full-year guidance, but is expected to resolve.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.